News & Analysis on Clinical Trial Services & Contract Research And Development
By Natalie Morrison
- Last updated on
Bergenham brings 16 years experience in the field to the oncology drugs development company.
"Egenix approach to treating cancer has the potential to prevent uncontrolled cancerous cell growth, while not affecting normally growing cells," said Nils Bergenhem. "I am very excited to join Egenix, and help drive these programs forward to clinical application."